Portland, ME, United States of America

Arvind Thakkar

This inventor holds 1 USPTO granted patent. Top assignee: Western University of Health Sciences. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arvind Thakkar. Retrieved from https://idiyas.com/inventor/arvind-thakkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arvind Thakkar: Innovator in Lipid Emulsified Drug Delivery Systems

Introduction

Arvind Thakkar is a notable inventor based in Portland, ME (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on enhancing the effectiveness of chemotherapeutic agents through lipid emulsified systems.

Latest Patents

Arvind Thakkar holds a patent for "Lipid emulsified drug delivery systems for chemoprevention and treatment." This patent discloses lipid emulsified systems containing antihistamines. It also includes pharmaceutical compositions that utilize these lipid emulsified systems alongside other chemotherapeutic agents. The methods outlined in his patent aim to improve chemoprevention and cancer treatment outcomes.

Career Highlights

Thakkar is affiliated with the Western University of Health Sciences, where he continues to advance research in drug delivery technologies. His work is pivotal in developing new therapeutic strategies that can potentially improve patient care in oncology.

Collaborations

Some of his notable coworkers include Sunil Prabhu and Preshita Desai, who contribute to the collaborative research efforts at the university.

Conclusion

Arvind Thakkar's innovative work in lipid emulsified drug delivery systems represents a significant advancement in the field of pharmaceutical sciences. His contributions are expected to have a lasting impact on cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…